Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for METROPOLIS
Revenue projections for METROPOLIS

Metropolis Healthcare Limited's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio 1.161000
forwardPE 37.133354
debtToEquity 13.916000
earningsGrowth 0.122000
revenueGrowth 0.227000
grossMargins 0.772700
operatingMargins 0.176650
trailingEps 30.470000
forwardEps 48.834800

METROPOLIS's current ratio 1.161, suggesting the company has sufficient liquidity to service its short-term debt. With its cash reserves and current assets in good shape, METROPOLIS can comfortably meet its immediate liabilities, reflecting a healthy financial standing.
METROPOLIS's low Debt-to-Equity ratio reflects that the company isn't heavily reliant on debt, reducing financial risk. This conservative approach suggests METROPOLIS maintains a stable financial foundation, with greater flexibility to manage future growth or challenges without over-leverage concerns.
METROPOLIS's positive earnings and revenue growth suggest that the company is poised for business expansion. This financial strength indicates that METROPOLIS is expected to continue growing, with rising profits and sales contributing to its long-term success.
With a forward EPS greater than its trailing EPS, METROPOLIS is forecasted to be more profitable this year than last. This growth expectation reflects confidence in the company's earnings potential and suggests an improving financial trajectory for the year ahead.

Price projections:

Price projections for METROPOLIS
Price projections for METROPOLIS

Over time, METROPOLIS's price projections have been revised higher, signaling growing confidence in the company's future. This upward trend suggests analysts anticipate strong performance and increased market value for METROPOLIS.

Recommendation changes over time:

Recommendations trend for METROPOLIS
Recommendations trend for METROPOLIS


Analysts have maintained a buy bias for METROPOLIS, which could prompt investors to consider the stock as a viable investment. With this positive outlook, METROPOLIS is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.